It has become apparent to everyone who is concerned about the lives of working Americans that the job losses from extreme economic shutdowns and the downstream consequences of those losses is far more damaging to the country than coronavirus disease. The cure has truly been far worse than the disease. So people are trying to figure some way out, one that gets the economy back to normal faster, while doing what we can to minimize risk for vulnerable populations. One such plan comes from Robert Shuler. (Shuler Plan) As is now very clear, and really was from the start of the epidemic, the risk of serious illness and death is extremely low for the vast majority of the population. And it is also clear that not allowing the virus to spread through the general population is extending the time until natural immunities build up. A vaccine, if one can be made, is too far off in the future for extreme lockdowns to be permitted indefinitely. So Mr. Shuler’s plan calls for periodic opening of economic and social life, say for three days a week. His theory is that this allows enough contact for “herd immunity” to build up while some closer semblance to normal business can resume. He is obviously trying to walk that line that doesn’t see the virus rip through vulnerable populations while also keeping people employed. It is an interesting approach and the paper at least gives you a lot of detail about their assumptions and their model. And it is the kind of realistic attempt that we need right now to find some way to balance the harms of various actions.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
April 18, 2024
Progress Against Cancer
The US has made particularly good progress in treating cancer and limiting mortality, but much…
Commentary
April 17, 2024
I Am Done With Coronamonomania, Part 4, Vax Safety Edition
A somewhat lengthy examination of recent studies related mostly to vax safety, the results of…
Commentary
April 16, 2024
Concentration of US Health Spending
Another version of my favorite brief on who is responsible for health is out, with…